van den Anker JN - Search Results

1

How to optimize the evaluation and use of antibiotics in neonates.

van den Anker JN. van den Anker JN. Early Hum Dev. 2014 Mar;90 Suppl 1:S10-2. doi: 10.1016/S0378-3782(14)70004-0. Early Hum Dev. 2014. PMID: 24709446 Review.

2

Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.

Zhao W, Hill H, Le Guellec C, Neal T, Mahoney S, Paulus S, Castellan C, Kassai B, van den Anker JN, Kearns GL, Turner MA, Jacqz-Aigrain E; TINN Consortium. Zhao W, et al. Among authors: van den anker jn. Antimicrob Agents Chemother. 2014 Nov;58(11):6572-80. doi: 10.1128/AAC.03568-14. Epub 2014 Aug 25. Antimicrob Agents Chemother. 2014. PMID: 25155587 Free PMC article. Clinical Trial.

3

A Delphi process to optimize quality and performance of drug evaluation in neonates.

Legrand F, Boulkedid R, Elie V, Leroux S, Valls E, Valls-i-Soler A, Van den Anker JN, Jacqz-Aigrain E. Legrand F, et al. Among authors: van den anker jn. PLoS One. 2014 Sep 11;9(9):e104976. doi: 10.1371/journal.pone.0104976. eCollection 2014. PLoS One. 2014. PMID: 25210742 Free PMC article.

4

Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.

Janssen EJ, Välitalo PA, Allegaert K, de Cock RF, Simons SH, Sherwin CM, Mouton JW, van den Anker JN, Knibbe CA. Janssen EJ, et al. Among authors: van den anker jn. Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15. Print 2016 Feb. Antimicrob Agents Chemother. 2015. PMID: 26643337 Free PMC article.

5

Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.

Wilbaux M, Fuchs A, Samardzic J, Rodieux F, Csajka C, Allegaert K, van den Anker JN, Pfister M. Wilbaux M, et al. Among authors: van den anker jn. J Clin Pharmacol. 2016 Aug;56(8):909-35. doi: 10.1002/jcph.705. Epub 2016 Mar 31. J Clin Pharmacol. 2016. PMID: 26766774 Review.

6

Pharmacokinetics of aminoglycosides in the newborn.

van den Anker JN, Allegaert K. van den Anker JN, et al. Curr Pharm Des. 2012;18(21):3114-8. Curr Pharm Des. 2012. PMID: 22564303

7

Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.

Ward RM, Allegaert K, de Groot R, van den Anker JN. Ward RM, et al. Among authors: van den anker jn. Pediatr Infect Dis J. 2014 Jun;33(6):606-7. doi: 10.1097/INF.0000000000000244. Pediatr Infect Dis J. 2014. PMID: 24378934 Free PMC article. No abstract available.

8

Topical nitroglycerin in neonates with tissue injury: A case report and review of the literature.

Samiee-Zafarghandy S, van den Anker JN, Ben Fadel N. Samiee-Zafarghandy S, et al. Among authors: van den anker jn. Paediatr Child Health. 2014 Jan;19(1):9-12. doi: 10.1093/pch/19.1.9. Paediatr Child Health. 2014. PMID: 24627647 Free PMC article.

9

Pharmacologic prevention of perinatal HIV infection.

Rakhmanina NY, van den Anker JN. Rakhmanina NY, et al. Among authors: van den anker jn. Early Hum Dev. 2014 Mar;90 Suppl 1:S13-5. doi: 10.1016/S0378-3782(14)70005-2. Early Hum Dev. 2014. PMID: 24709447 Review.

10

The impact of therapeutic drug monitoring in neonatal clinical pharmacology.

van den Anker JN. van den Anker JN. Clin Biochem. 2014 Jun;47(9):704-5. doi: 10.1016/j.clinbiochem.2014.05.018. Epub 2014 May 19. Clin Biochem. 2014. PMID: 24854683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters